Abstract
Background A 14-year-old boy presented with daytime somnolence, intermittent emesis and hypothyroidism. Neuroimaging revealed a calcified suprasellar intracranial mass, suspected to be a craniopharyngioma. Subtotal resection of the tumor confirmed the diagnosis. Extreme obesity (BMI >60 kg/m2) and hyperinsulinemia followed tumor resection and cranial irradiation. Dietary interventions were unsuccessful, and pharmacologic intervention (i.e. octreotide) only slowed the rate of weight gain.
Investigations Radiography documented the suprasellar mass. Following surgical resection and radiotherapy, hypothalamic–pituitary deficiencies were found. Preprandial and postprandial excursions of insulin, active ghrelin and leptin were measured before and after gastric bypass surgery.
Diagnosis Panhypopituitarism, hypothalamic obesity and hyperinsulinemia following craniopharyngioma therapy.
Management Severe caloric restriction, octreotide, and pituitary hormone replacement did not produce weight loss. Gastric bypass surgery led to reduced food cravings, significant weight loss, and amelioration of obesity-related comorbidities. Correction of fasting hyperinsulinemia, normalization of postprandial insulin responses, and reductions in active ghrelin and leptin concentrations were also observed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lustig RH et al. (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88: 2586–2592
Gold RM et al. (1980) Vagal mediation of hypothalamic obesity but not of supermarket dietary obesity. Am J Physiol 238: R447–R453
Lustig RH (2006) Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab 2: 447–458
Haupt R et al. (2006) Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab 19 (Suppl 1): S289–S293
Hopper N et al. (2006) The pre-operative endocrine assessment of craniopharyngiomas. J Pediatr Endocrinol Metab 19 (Suppl 1): S325–S327
Eyal O et al. (2006) Obesity in patients with craniopharyngioma. Endocrinologist 16: 286–293
Hoffman HJ et al. (1992) Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76: 47–52
Pinto G et al. (2000) Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 53: 163–169
Srinivasan S et al. (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89: 81–86
Lustig RH (2001) The neuroendocrinology of childhood obesity. Pediatr Clin North Am 48: 909–930
le Roux CW et al. (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243: 108–114
Cummings DE et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346: 1623–1630
Hewson AK and Dickson SL (2000) Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 12: 1047–1049
Hou Z et al. (2006) Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 134: 126–131
Abizaid A et al. (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116: 3229–3239
White MA et al. (2002) Development and validation of the food-craving inventory. Obes Res 10: 107–114
Acknowledgements
Written consent for publication was obtained from the patient's responsible relative.The authors would like to express gratitude for the helpful scientific input of R Lustig, R Seeley, J Kral, M Vierra, and D D'Alessio. In addition, we appreciate the expert clinical care provided by V Garcia, S Kirk, S Xanthakos, H Roehrig, and J Sweeney.This work was supported in part by an NIH General Clinical Research Center grant #M01 RR 08084 including Clinical Research Feasibility Funding (CReFF) funding to MZ.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Inge, T., Pfluger, P., Zeller, M. et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Rev Endocrinol 3, 606–609 (2007). https://doi.org/10.1038/ncpendmet0579
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0579
This article is cited by
-
Five-Year Changes in Weight and Diabetes Status After Bariatric Surgery for Craniopharyngioma-Related Hypothalamic Obesity: a Case–Control Study
Obesity Surgery (2022)
-
Bariatric Surgery for Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy: a Matched Case–Control Study
Obesity Surgery (2020)
-
Craniopharyngioma
Nature Reviews Disease Primers (2019)
-
Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case–control study with 2 years of follow-up
International Journal of Obesity (2017)
-
Late endocrine effects of childhood cancer
Nature Reviews Endocrinology (2016)